Half of every dollar invested in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) rides on just two companies pulling in ...
The Office of the National Coordinator for Health IT has entered into a cooperative agreement with Integrating the Health Enterprise USA to jointly advance interoperability goals. Together, ONC and ...
iShares U.S. Pharmaceuticals ETF is a pharmaceutical ETF offered by iShares, featuring an expense ratio of 0.39% and over $500 million in assets under management. In Q3, the healthcare sector reported ...
The first strong outlook factor for IHE is its inclusion of Eli Lilly at almost 27% weight. The pharmaceutical company has seen tremendous growth due to Mounjaro, approved by the FDA in 2022, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results